Skip to main navigation Skip to search Skip to main content

Long-Term Follow-Up Protocol for Subjects Treated with Gene-Modified T Cells

Grants and Contracts Details

StatusActive
Effective start/end date8/12/20 → 3/12/27

Funding

  • Celgene: $40,583.00